{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/705015637",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/702525006"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#705015637",
  "code": "2A84.1",
  "source": "http://id.who.int/icd/entity/705015637",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/705015637/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/322466810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Gamma heavy chain disease"
  },
  "definition": {
    "@language": "en",
    "@value": "A clonal disorder characterised by the secretion of a truncated gamma chain. In most cases, it is associated with morphologic changes also seen in lymphoplasmacytic lymphomas, but the clinical course is typically more aggressive than in lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia."
  },
  "inclusion": [
    {
      "label": {
        "@language": "en",
        "@value": "Franklin disease"
      }
    }
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Gamma heavy chain disease"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Franklin disease"
      }
    }
  ]
}